Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015
Supporting Files
-
7 02 2019
-
Available in CDC Stacks on 2024-05-22T00:00:00Z
File Language:
English
Details
-
Alternative Title:J Infect Dis
-
Personal Author:Abara, Winston E. ; Trujillo, Lindsay ; Broz, Dita ; Finlayson, Teresa ; Teshale, Eyasu ; Paz-Bailey, Gabriela ; Glick, Sara ; Al-Tayyib, Alia A. ; Robinson, William T. ; Masiello-Schuette, Stephanie ; Sey, Ekow K. ; Anderson, Bridget J. ; Poe, Jonathon ; Braunstein, Sarah
-
Description:Background. ; Historically, older people who inject drugs (PWID) have had the highest hepatitis C virus (HCV) burden; however, young PWID now account for recent increases. We assessed factors associated with past or present HCV infection (HCV antibody anti-HCV positive) among young (≤35 years) and older (>35 years) PWID. ; Methods. ; We calculated adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) to examine sociodemographic and past 12-month injection behaviors associated with HCV infection. ; Results. ; Of 4094 PWID, 55.2% were anti-HCV positive. Among young PWID, anti-HCV prevalence was 42.1% and associated with ≤high school diploma/General Education Development diploma (GED) (aPR, 1.17 95% CI, 1.03–1.33), receptive syringe sharing (aPR, 1.37 95% CI, 1.21–1.56), sharing injection equipment (aPR, 1.16 95% CI, 1.01–1.35), arrest history (aPR, 1.14 95% CI, 1.02–1.29), and injecting speedball (aPR, 1.37 95% CI, 1.16–1.61). Among older PWID, anti-HCV prevalence was 62.2% and associated with ≤high school diploma/GED (aPR, 1.08 95% CI, 1.02–1.15), sharing injection equipment (aPR, 1.08 95% CI, 1.02–1.15), high injection frequency (aPR, 1.16 95% CI, 1.01–1.34), and injecting speedball (aPR, 1.09 95% CI, 1.01–1.16) ; Conclusions. ; Anti-HCV prevalence is high among PWID and varies with age. Scaling up direct-acting antiviral treatment, syringe service programs, and medication-assisted therapy is critical to mitigating transmission risk and infection burden.
-
Subjects:
-
Keywords:
-
Source:J Infect Dis. 220(3):377-385
-
Pubmed ID:30915477
-
Pubmed Central ID:PMC11111175
-
Document Type:
-
Funding:
-
Volume:220
-
Issue:3
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:03fd3f868792973f6a4efd0f214ed4050e0a96ce630172a65903f9a68c7f0c07
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access